Tom Anchordoquy, PhD, hates cancer. And, for most of his professional life as a professor and researcher with the Skaggs School of Pharmacy and Pharmaceutical Sciences, he’s been focused on new ways to deliver drugs to tumors. His latest research, however, is taking a different approach.
Lori Westermann | 
July 13, 2023
Faculty Pharmacy Perspectives Cancer Pharmacy
Professor. Researcher. Fulbright awardee. Cindy O’Bryant, PharmD, can now add Associate Dean for Academic and Faculty Affairs to her impressive CV.
Jordan Kellerman | June 28, 2022
Faculty Cancer Pharmacy Oncology
NOTE: This article originally appeared in Pharmacy Practice News; Dave Doolittle, writer.
Cindy O’Bryant, PharmD, didn’t know quite what to expect in the days leading up to a trip to Nigeria late last year that was designed to help strengthen cancer treatment and care in the African nation. Although she has met several Nigerian healthcare professionals and students as a clinical pharmacy professor at the University of Colorado Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences she had no first-hand knowledge of how her colleagues there treated cancer patients.
Guest Contributor | May 03, 2022
Drug Topics
September 07, 2023
Danielle Fixen, PharmD, notes that the role of a pharmacist varies depending on the state, but that pharmacists can perform drug-interaction checks and educate patients on potential side effects they may experience. “Some states have pharmacists within the medical marijuana dispensary while others do not,” she said. “Given the multiple drug interactions with cannabis, it is important to evaluate [its] safety...in patients.”
Cannabis Now
August 24, 2023
A new study shows that maybe cannabis doesn't increase heart attack risks, but this study is inconsistent with previous research. Dr. Robert Page, PharmD, noted that “the way cannabis is consumed may make a difference in how it affects the heart and blood vessels. Many people don’t realize that cannabis smoke contains components similar to tobacco smoke.”
Congressionally Directed Medical Research Programs
July 27, 2023
Dr. Daniel LaBarbera’s laboratory is engaged in multidisciplinary cancer drug discovery and development - and has been featured in a 2023 peer reviewed cancer research highlight by the DOD's Congressionally Directed Medical Research Programs (CDMRP).
KDVR
July 19, 2023
As electronic dance music fans listen to their favorite music this weekend, organizers of the Keep the Party Safe campaign, an effort of CU Pharmacy and the Colorado Consortium for Prescription Drug Abuse Prevention, hope they tune into this message: “We want people to be safe, we want people equipped, we want people to be empowered."
